| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 1.24e-12 | 5 | 85 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 7.42e-12 | 6 | 85 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 5.22e-09 | 16 | 85 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.70e-06 | 144 | 85 | 7 | GO:0016798 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.12e-05 | 118 | 85 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.21e-05 | 70 | 85 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 4.85e-05 | 17 | 85 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 7.83e-05 | 103 | 85 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | DNA-methyltransferase activity | 3.71e-04 | 7 | 85 | 2 | GO:0009008 | |
| GeneOntologyMolecularFunction | actin filament binding | 4.18e-04 | 227 | 85 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.79e-04 | 441 | 85 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPTBN4 EZR DLC1 MYLK KIF1A MYO9B SPTB KIF1B ACTR3B NEB ADNP FKBP4 KIF1C | 7.29e-04 | 1099 | 85 | 13 | GO:0008092 |
| GeneOntologyMolecularFunction | interleukin-1 binding | 1.15e-03 | 12 | 85 | 2 | GO:0019966 | |
| GeneOntologyMolecularFunction | NAD+ nucleosidase activity | 1.15e-03 | 12 | 85 | 2 | GO:0003953 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.65e-03 | 775 | 85 | 10 | GO:0017111 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 2.07e-03 | 16 | 85 | 2 | GO:0061809 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor binding | 2.34e-03 | 17 | 85 | 2 | GO:0005161 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.62e-03 | 18 | 85 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 2.95e-03 | 839 | 85 | 10 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 2.97e-03 | 840 | 85 | 10 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 2.97e-03 | 840 | 85 | 10 | GO:0016818 | |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 3.57e-03 | 21 | 85 | 2 | GO:1990380 | |
| GeneOntologyMolecularFunction | ankyrin binding | 4.28e-03 | 23 | 85 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | actin binding | 4.32e-03 | 479 | 85 | 7 | GO:0003779 | |
| GeneOntologyBiologicalProcess | retrograde neuronal dense core vesicle transport | 1.25e-06 | 6 | 83 | 3 | GO:1990049 | |
| GeneOntologyBiologicalProcess | anterograde neuronal dense core vesicle transport | 3.47e-06 | 8 | 83 | 3 | GO:1990048 | |
| GeneOntologyBiologicalProcess | dense core granule cytoskeletal transport | 1.35e-05 | 12 | 83 | 3 | GO:0099519 | |
| GeneOntologyBiologicalProcess | dense core granule transport | 2.22e-05 | 14 | 83 | 3 | GO:1901950 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression via chromosomal CpG island methylation | 1.05e-04 | 23 | 83 | 3 | GO:0044027 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 1.20e-04 | 24 | 83 | 3 | GO:0008090 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 1.62e-04 | 493 | 83 | 9 | GO:0007018 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 1.91e-04 | 28 | 83 | 3 | GO:0032253 | |
| GeneOntologyCellularComponent | axon | SPTBN4 IL1RAPL1 COPA KIF1A SYNJ2 SCN1A KIF1B GRIA3 IL1R1 ADNP ENO1 FKBP4 GABBR1 KIF1C | 1.34e-05 | 891 | 85 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | supramolecular fiber | SPTBN4 EZR DLC1 KIF1A SYNJ2 MYO9B SCN1A KIF1B NEB ENO1 DNAH9 DNAH7 FKBP4 KIF1C | 2.70e-04 | 1179 | 85 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | SPTBN4 EZR DLC1 KIF1A SYNJ2 MYO9B SCN1A KIF1B NEB ENO1 DNAH9 DNAH7 FKBP4 KIF1C | 2.90e-04 | 1187 | 85 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | somatodendritic compartment | SPTBN4 IL1RAPL1 COPA KIF1A SCN1A KIF1B SORCS2 PSMC2 GRIA3 RABGEF1 ADNP FKBP4 GABBR1 KIF1C | 4.08e-04 | 1228 | 85 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | microtubule associated complex | 5.09e-04 | 161 | 85 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | spectrin | 5.77e-04 | 9 | 85 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | cell leading edge | 9.73e-04 | 500 | 85 | 8 | GO:0031252 | |
| GeneOntologyCellularComponent | ruffle membrane | 9.89e-04 | 108 | 85 | 4 | GO:0032587 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | SPTBN4 EZR DLC1 KIF1A SYNJ2 MYO9B KIF1B DNAH9 DNAH7 FKBP4 KIF1C | 1.02e-03 | 899 | 85 | 11 | GO:0099513 |
| GeneOntologyCellularComponent | kinesin complex | 1.04e-03 | 49 | 85 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | ruffle | 1.53e-03 | 206 | 85 | 5 | GO:0001726 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.67e-03 | 210 | 85 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.87e-03 | 431 | 85 | 7 | GO:0031253 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.91e-03 | 129 | 85 | 4 | GO:0030863 | |
| HumanPheno | Abnormality of the joints of the lower limbs | DHX16 SPTBN4 COL6A2 KIF1A SCN1A GRIA3 NEB ADNP ANKLE2 CSGALNACT1 DNMT3A KIF1C CDC45 | 7.26e-06 | 547 | 31 | 13 | HP:0100239 |
| HumanPheno | Abnormality of the knee | DHX16 COL6A2 KIF1A SCN1A GRIA3 NEB ADNP ANKLE2 CSGALNACT1 DNMT3A KIF1C CDC45 | 1.43e-05 | 491 | 31 | 12 | HP:0002815 |
| Domain | Aamy_C | 3.81e-10 | 4 | 84 | 4 | SM00632 | |
| Domain | Alpha_amylase | 3.81e-10 | 4 | 84 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 1.90e-09 | 5 | 84 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 1.90e-09 | 5 | 84 | 4 | IPR006048 | |
| Domain | Aamy | 1.32e-08 | 7 | 84 | 4 | SM00642 | |
| Domain | Glyco_hydro_13_cat_dom | 1.32e-08 | 7 | 84 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 1.32e-08 | 7 | 84 | 4 | PF00128 | |
| Domain | A-amylase_C | 8.78e-08 | 3 | 84 | 3 | IPR031319 | |
| Domain | Glyco_hydro_b | 5.00e-07 | 15 | 84 | 4 | IPR013780 | |
| Domain | Kinesin_assoc | 1.74e-06 | 6 | 84 | 3 | PF16183 | |
| Domain | Glyco_hydro_13 | 1.74e-06 | 6 | 84 | 3 | IPR015902 | |
| Domain | Kinesin_assoc | 1.74e-06 | 6 | 84 | 3 | IPR032405 | |
| Domain | Glyco_hydro_catalytic_dom | 2.50e-05 | 38 | 84 | 4 | IPR013781 | |
| Domain | - | 3.08e-05 | 14 | 84 | 3 | 2.60.40.1180 | |
| Domain | Glycoside_hydrolase_SF | 9.43e-05 | 53 | 84 | 4 | IPR017853 | |
| Domain | Kinesin-like_KIF1-typ | 1.19e-04 | 4 | 84 | 2 | IPR022140 | |
| Domain | KIF1B | 1.19e-04 | 4 | 84 | 2 | PF12423 | |
| Domain | Spectrin_bsu | 1.19e-04 | 4 | 84 | 2 | IPR016343 | |
| Domain | FHA | 2.65e-04 | 28 | 84 | 3 | SM00240 | |
| Domain | DUF3694 | 2.96e-04 | 6 | 84 | 2 | PF12473 | |
| Domain | Kinesin-like | 2.96e-04 | 6 | 84 | 2 | IPR022164 | |
| Domain | FHA_DOMAIN | 3.60e-04 | 31 | 84 | 3 | PS50006 | |
| Domain | FHA | 3.60e-04 | 31 | 84 | 3 | PF00498 | |
| Domain | - | 5.18e-04 | 35 | 84 | 3 | 3.20.20.80 | |
| Domain | FHA_dom | 5.63e-04 | 36 | 84 | 3 | IPR000253 | |
| Domain | - | 5.63e-04 | 36 | 84 | 3 | 2.60.200.20 | |
| Domain | Kinesin_motor_CS | 8.27e-04 | 41 | 84 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 9.51e-04 | 43 | 84 | 3 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 1.02e-03 | 44 | 84 | 3 | PS00411 | |
| Domain | - | 1.02e-03 | 44 | 84 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.02e-03 | 44 | 84 | 3 | IPR001752 | |
| Domain | Kinesin | 1.02e-03 | 44 | 84 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.02e-03 | 44 | 84 | 3 | PS50067 | |
| Domain | KISc | 1.02e-03 | 44 | 84 | 3 | SM00129 | |
| Domain | IL-1_rcpt_fam | 1.07e-03 | 11 | 84 | 2 | IPR015621 | |
| Domain | TPR_2 | 1.48e-03 | 50 | 84 | 3 | PF07719 | |
| Domain | TPR_2 | 1.48e-03 | 50 | 84 | 3 | IPR013105 | |
| Domain | SMAD_FHA_domain | 1.65e-03 | 52 | 84 | 3 | IPR008984 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.76e-03 | 14 | 84 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.76e-03 | 14 | 84 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.76e-03 | 14 | 84 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.76e-03 | 14 | 84 | 2 | PF08393 | |
| Domain | MT | 1.76e-03 | 14 | 84 | 2 | PF12777 | |
| Domain | AAA_8 | 1.76e-03 | 14 | 84 | 2 | PF12780 | |
| Domain | DHC_fam | 2.02e-03 | 15 | 84 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.02e-03 | 15 | 84 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.02e-03 | 15 | 84 | 2 | PF03028 | |
| Domain | RhoGAP | 2.74e-03 | 62 | 84 | 3 | SM00324 | |
| Domain | RhoGAP | 2.87e-03 | 63 | 84 | 3 | PF00620 | |
| Domain | RHOGAP | 3.00e-03 | 64 | 84 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 3.00e-03 | 64 | 84 | 3 | IPR000198 | |
| Domain | - | 3.00e-03 | 64 | 84 | 3 | 1.10.555.10 | |
| Domain | TIR | 3.97e-03 | 21 | 84 | 2 | SM00255 | |
| Domain | TIR | 4.36e-03 | 22 | 84 | 2 | PF01582 | |
| Domain | P-loop_NTPase | 4.67e-03 | 848 | 84 | 10 | IPR027417 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 2.79e-10 | 9 | 68 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.02e-09 | 11 | 68 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 7.07e-08 | 23 | 68 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.03e-07 | 28 | 68 | 5 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.90e-06 | 52 | 68 | 5 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 5.91e-06 | 8 | 68 | 3 | MM14717 | |
| Pathway | REACTOME_DIGESTION | 1.34e-04 | 21 | 68 | 3 | MM15526 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | SPTBN4 COPA KIF1A SYNJ2 SPTB KIF1B RALGAPB RABGEF1 DENND2D GGA3 KIF1C | 1.96e-04 | 630 | 68 | 11 | M11480 |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.29e-04 | 25 | 68 | 3 | MM15557 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 5.22e-13 | 6 | 87 | 5 | 6608795 | |
| Pubmed | 5.22e-13 | 6 | 87 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 5.22e-13 | 6 | 87 | 5 | 2788608 | |
| Pubmed | 5.22e-13 | 6 | 87 | 5 | 2081604 | ||
| Pubmed | 5.22e-13 | 6 | 87 | 5 | 15286789 | ||
| Pubmed | 4.85e-12 | 8 | 87 | 5 | 12414807 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 3.65e-11 | 4 | 87 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 3.65e-11 | 4 | 87 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 3.65e-11 | 4 | 87 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 3.65e-11 | 4 | 87 | 4 | 26098870 | |
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 6160849 | ||
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 3.65e-11 | 4 | 87 | 4 | 4745489 | |
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 3.65e-11 | 4 | 87 | 4 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 3.65e-11 | 4 | 87 | 4 | 94264 | |
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 3872721 | ||
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 3.65e-11 | 4 | 87 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 3.65e-11 | 4 | 87 | 4 | 6207174 | |
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 2410924 | ||
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 3.65e-11 | 4 | 87 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 3.65e-11 | 4 | 87 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 3.65e-11 | 4 | 87 | 4 | 2987507 | |
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 6091898 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 3.65e-11 | 4 | 87 | 4 | 2332419 | |
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 3.65e-11 | 4 | 87 | 4 | 6162108 | |
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 16152770 | ||
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 2423416 | ||
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 3.65e-11 | 4 | 87 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 3.65e-11 | 4 | 87 | 4 | 2989529 | |
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 1.71e-10 | 14 | 87 | 5 | 8001974 | |
| Pubmed | 1.82e-10 | 5 | 87 | 4 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.82e-10 | 5 | 87 | 4 | 34276419 | |
| Pubmed | 1.82e-10 | 5 | 87 | 4 | 6176569 | ||
| Pubmed | 1.82e-10 | 5 | 87 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.82e-10 | 5 | 87 | 4 | 8661735 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 5.46e-10 | 6 | 87 | 4 | 7859283 | |
| Pubmed | 5.46e-10 | 6 | 87 | 4 | 2002257 | ||
| Pubmed | 5.46e-10 | 6 | 87 | 4 | 2450406 | ||
| Pubmed | 5.46e-10 | 6 | 87 | 4 | 7946325 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 5.46e-10 | 6 | 87 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 5.46e-10 | 6 | 87 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 5.46e-10 | 6 | 87 | 4 | 9250879 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 5.46e-10 | 6 | 87 | 4 | 1021597 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 1.27e-09 | 7 | 87 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 1.27e-09 | 7 | 87 | 4 | 2451911 | |
| Pubmed | 1.27e-09 | 7 | 87 | 4 | 7949740 | ||
| Pubmed | 1.27e-09 | 7 | 87 | 4 | 6160178 | ||
| Pubmed | 1.27e-09 | 7 | 87 | 4 | 8604219 | ||
| Pubmed | 1.27e-09 | 7 | 87 | 4 | 8666240 | ||
| Pubmed | 2.54e-09 | 8 | 87 | 4 | 2040456 | ||
| Pubmed | 2.54e-09 | 8 | 87 | 4 | 3038891 | ||
| Pubmed | 2.54e-09 | 8 | 87 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 2.54e-09 | 8 | 87 | 4 | 6200103 | |
| Pubmed | 2.54e-09 | 8 | 87 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 2.54e-09 | 8 | 87 | 4 | 7523515 | |
| Pubmed | 4.56e-09 | 9 | 87 | 4 | 93520 | ||
| Pubmed | 7.58e-09 | 10 | 87 | 4 | 9121556 | ||
| Pubmed | 7.58e-09 | 10 | 87 | 4 | 2897103 | ||
| Pubmed | 1.19e-08 | 11 | 87 | 4 | 23449223 | ||
| Pubmed | 1.19e-08 | 11 | 87 | 4 | 2565740 | ||
| Pubmed | 1.19e-08 | 11 | 87 | 4 | 7608209 | ||
| Pubmed | 1.19e-08 | 11 | 87 | 4 | 1617215 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.19e-08 | 11 | 87 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 1.19e-08 | 11 | 87 | 4 | 8589528 | |
| Pubmed | 1.19e-08 | 11 | 87 | 4 | 2903254 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.51e-08 | 3 | 87 | 3 | 2413838 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 6098446 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.51e-08 | 3 | 87 | 3 | 21827821 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 30982860 | ||
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.51e-08 | 3 | 87 | 3 | 6360562 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.51e-08 | 3 | 87 | 3 | 2436036 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 1699843 | ||
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.51e-08 | 3 | 87 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.51e-08 | 3 | 87 | 3 | 17223109 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15299664 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 12527308 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 2414282 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 8413315 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 28659346 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 23404705 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 1.51e-08 | 3 | 87 | 3 | 7678001 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25588701 | ||
| Pubmed | 1.78e-08 | 12 | 87 | 4 | 8144363 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 2.57e-08 | 13 | 87 | 4 | 7829080 | |
| Pubmed | 2.57e-08 | 13 | 87 | 4 | 489953 | ||
| Pubmed | 3.09e-08 | 36 | 87 | 5 | 7558020 | ||
| Pubmed | 3.59e-08 | 14 | 87 | 4 | 7894156 | ||
| Pubmed | 3.59e-08 | 14 | 87 | 4 | 2902233 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 20939500 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 6.04e-08 | 4 | 87 | 3 | 8543783 | |
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 6.04e-08 | 4 | 87 | 3 | 16786601 | |
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 2458567 | ||
| Pubmed | 6.50e-08 | 16 | 87 | 4 | 2571572 | ||
| Pubmed | 6.50e-08 | 16 | 87 | 4 | 10842072 | ||
| Interaction | AMY2B interactions | 8.51e-06 | 10 | 85 | 3 | int:AMY2B | |
| Interaction | KIF1C interactions | 1.17e-05 | 120 | 85 | 6 | int:KIF1C | |
| Interaction | UBC interactions | 1.81e-05 | 446 | 85 | 10 | int:UBC | |
| Cytoband | 1p21 | 8.99e-10 | 24 | 87 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 1.99e-06 | 107 | 87 | 5 | chr1p21 | |
| Cytoband | 1p36.2 | 2.73e-04 | 13 | 87 | 2 | 1p36.2 | |
| Cytoband | 6q25.3 | 1.80e-03 | 33 | 87 | 2 | 6q25.3 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.03e-04 | 7 | 57 | 2 | 1113 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.10e-04 | 46 | 57 | 3 | 622 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.73e-04 | 206 | 57 | 5 | 682 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 9.99e-04 | 15 | 57 | 2 | 1296 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 9.99e-04 | 15 | 57 | 2 | 529 | |
| GeneFamily | Dyneins, axonemal | 1.29e-03 | 17 | 57 | 2 | 536 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.71e-03 | 115 | 57 | 3 | 769 | |
| GeneFamily | Ankyrin repeat domain containing | 7.10e-03 | 242 | 57 | 4 | 403 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 7.75e-03 | 42 | 57 | 2 | 602 | |
| GeneFamily | Proteasome | 8.12e-03 | 43 | 57 | 2 | 690 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.09e-02 | 50 | 57 | 2 | 1293 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 1.21e-02 | 53 | 57 | 2 | 103 | |
| Coexpression | BERGER_MBD2_TARGETS | 5.52e-06 | 11 | 86 | 3 | MM905 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 9.97e-06 | 41 | 86 | 4 | MM698 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 1.72e-05 | 97 | 86 | 5 | MM1016 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 3.36e-05 | 185 | 86 | 6 | MM1072 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 4.07e-05 | 116 | 86 | 5 | MM1240 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 4.58e-05 | 60 | 86 | 4 | MM654 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 4.71e-05 | 289 | 86 | 7 | MM1238 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP | 5.04e-05 | 199 | 86 | 6 | M8863 | |
| Coexpression | GSE360_CTRL_VS_T_GONDII_MAC_UP | 5.18e-05 | 200 | 86 | 6 | M5162 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 7.54e-05 | 132 | 86 | 5 | MM470 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_5 | 8.10e-05 | 134 | 86 | 5 | M15659 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 9.42e-05 | 27 | 86 | 3 | MM643 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_5 | 1.17e-04 | 145 | 86 | 5 | MM517 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | PRSS35 COL6A2 THBS2 MYLK COPA ADAMTS9 PIK3R1 QPRT PDZK1 KIF1B ANKRD10 USP7 GRIA3 PI15 AGAP1 DNMT3A | 9.66e-08 | 799 | 85 | 16 | gudmap_developingGonad_e18.5_epididymis_1000 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-06 | 169 | 87 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.50e-06 | 181 | 87 | 6 | 1cfb03eb03a37b036b4eeacec69c9b8163af1ee4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-06 | 185 | 87 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-06 | 190 | 87 | 6 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-06 | 198 | 87 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | fc2fc3bfcf1ad9bfb9fe07bbed8068126930bee6 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.97e-05 | 168 | 87 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.27e-05 | 173 | 87 | 5 | 5295ed31648abf8edff214cf67cd4769f20f9e6d | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-05 | 182 | 87 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 185 | 87 | 5 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 185 | 87 | 5 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 185 | 87 | 5 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 3.21e-05 | 186 | 87 | 5 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.30e-05 | 187 | 87 | 5 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.56e-05 | 190 | 87 | 5 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.56e-05 | 190 | 87 | 5 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.65e-05 | 191 | 87 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-05 | 191 | 87 | 5 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 3.65e-05 | 191 | 87 | 5 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.83e-05 | 193 | 87 | 5 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.83e-05 | 193 | 87 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LAM-LAM-LAM+|LAM / Condition, Lineage and Cell class | 3.93e-05 | 194 | 87 | 5 | 4ba73a9145ed44896e359f6df9c1f32bbe24a189 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 194 | 87 | 5 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 194 | 87 | 5 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | LAM-LAM|LAM / Condition, Lineage and Cell class | 3.93e-05 | 194 | 87 | 5 | 4c6561a64711c72c4ef4a3e67c41d2e8d31fba57 | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 3.93e-05 | 194 | 87 | 5 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.02e-05 | 195 | 87 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-05 | 195 | 87 | 5 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 195 | 87 | 5 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-05 | 195 | 87 | 5 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 195 | 87 | 5 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.02e-05 | 195 | 87 | 5 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.12e-05 | 196 | 87 | 5 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.12e-05 | 196 | 87 | 5 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-05 | 197 | 87 | 5 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.22e-05 | 197 | 87 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-05 | 198 | 87 | 5 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.33e-05 | 198 | 87 | 5 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.33e-05 | 198 | 87 | 5 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 4.33e-05 | 198 | 87 | 5 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 4.33e-05 | 198 | 87 | 5 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.33e-05 | 198 | 87 | 5 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 4.43e-05 | 199 | 87 | 5 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 199 | 87 | 5 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.43e-05 | 199 | 87 | 5 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 199 | 87 | 5 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.43e-05 | 199 | 87 | 5 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 199 | 87 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 199 | 87 | 5 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-05 | 199 | 87 | 5 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 199 | 87 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.43e-05 | 199 | 87 | 5 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 4.43e-05 | 199 | 87 | 5 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 199 | 87 | 5 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.43e-05 | 199 | 87 | 5 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 4.43e-05 | 199 | 87 | 5 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.54e-05 | 200 | 87 | 5 | c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.54e-05 | 200 | 87 | 5 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.54e-05 | 200 | 87 | 5 | 137f8f9d255c66336d4f8b44b2e3f3de721f2bf0 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 4.54e-05 | 200 | 87 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.54e-05 | 200 | 87 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.54e-05 | 200 | 87 | 5 | 93c1db92e0e456101f7895867fc8a1fe45298347 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.54e-05 | 200 | 87 | 5 | 6ce8e2cf689523993d909a27daec3d6a5824d13c | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.54e-05 | 200 | 87 | 5 | 907427e85cebe5a18c8a310e2ffa0e180ea3cb77 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.54e-05 | 200 | 87 | 5 | 3be373e9a30e19334e4709e2819fb83cc777d104 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-05 | 200 | 87 | 5 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.54e-05 | 200 | 87 | 5 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-05 | 200 | 87 | 5 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.54e-05 | 200 | 87 | 5 | 25d3865aa2ced11a5ed40013e83b47d942fdf582 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.54e-05 | 200 | 87 | 5 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.54e-05 | 200 | 87 | 5 | 46d0ae385e67030bfaf7062bb6b43da5db05b33a | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.54e-05 | 200 | 87 | 5 | 8472baa74c48b67c5f08223025885c833458290b | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 5.17e-05 | 37 | 87 | 3 | 5208860d6b87c6c6fbf6e6c262fb2efc712ec2d3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-04 | 126 | 87 | 4 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.59e-04 | 139 | 87 | 4 | fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48 | |
| ToppCell | MS-CD4-CD8_1|MS / Condition, Cell_class and T cell subcluster | 2.13e-04 | 150 | 87 | 4 | 7dc95c58b98d8c4c6c49fb1a03ec6ac24fb41f54 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-04 | 152 | 87 | 4 | 18194f757d319958f26e5a91f56d89f25711236f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-04 | 153 | 87 | 4 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | VE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 2.47e-04 | 156 | 87 | 4 | 6501baf73616e702946de9fb13d267e30a68888b | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.66e-04 | 159 | 87 | 4 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.73e-04 | 160 | 87 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-04 | 161 | 87 | 4 | 8fe9fde47e691c443d13d8616c654fbae2d5675c | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.79e-04 | 161 | 87 | 4 | 048b7dc00746987a24bf870d4d278c4183eb04a2 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.79e-04 | 161 | 87 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-04 | 165 | 87 | 4 | 35a6de30438de364ccca948fc932da541a69ef89 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 165 | 87 | 4 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.21e-04 | 167 | 87 | 4 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-04 | 167 | 87 | 4 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 167 | 87 | 4 | d72b08b3cbc34b30a11dcf512e472b64d1606ec1 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 3.21e-04 | 167 | 87 | 4 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 167 | 87 | 4 | 22f7384ff2044898d7b0b01cb9d9a3cbaa93a9a3 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 169 | 87 | 4 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-04 | 170 | 87 | 4 | 09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 3.51e-04 | 171 | 87 | 4 | dcb6c41980008d0b9eeb54999faff77311554976 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 3.51e-04 | 171 | 87 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-04 | 171 | 87 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-04 | 171 | 87 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.59e-04 | 172 | 87 | 4 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-04 | 172 | 87 | 4 | eee45759284baa3ed77da6a5fbcc4f8f6c553106 | |
| Drug | R 623 | 3.85e-12 | 6 | 85 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 3.85e-12 | 6 | 85 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 3.85e-12 | 6 | 85 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 3.85e-12 | 6 | 85 | 5 | CID000127364 | |
| Drug | CNP-G3 | 3.85e-12 | 6 | 85 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 1.34e-11 | 7 | 85 | 5 | CID000174858 | |
| Drug | Paramax | 1.34e-11 | 7 | 85 | 5 | CID000156411 | |
| Drug | BG5P | 1.34e-11 | 7 | 85 | 5 | CID003082752 | |
| Drug | desethylaprophen | 3.57e-11 | 8 | 85 | 5 | CID000163919 | |
| Drug | azintamide | 3.57e-11 | 8 | 85 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 8.02e-11 | 9 | 85 | 5 | CID000194237 | |
| Drug | trestatin A | 8.02e-11 | 9 | 85 | 5 | CID003054994 | |
| Drug | AC1LAC07 | 1.60e-10 | 10 | 85 | 5 | CID000485275 | |
| Drug | Glc)4 | 1.60e-10 | 10 | 85 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 1.60e-10 | 10 | 85 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 1.60e-10 | 10 | 85 | 5 | CID000118008 | |
| Drug | N-PMT | 1.81e-10 | 4 | 85 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 1.81e-10 | 4 | 85 | 4 | CID003482066 | |
| Drug | SAIB-SG | 1.81e-10 | 4 | 85 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 1.81e-10 | 4 | 85 | 4 | CID013573844 | |
| Drug | Dembrexine | 1.81e-10 | 4 | 85 | 4 | CID000072009 | |
| Drug | g lw | 1.81e-10 | 4 | 85 | 4 | CID000444139 | |
| Drug | beta-santalene | 1.81e-10 | 4 | 85 | 4 | CID000010534 | |
| Drug | validamycin D | 2.92e-10 | 11 | 85 | 5 | CID000166726 | |
| Drug | FG5P | 2.92e-10 | 11 | 85 | 5 | CID000127486 | |
| Drug | CNP-G5 | 2.92e-10 | 11 | 85 | 5 | CID000127309 | |
| Drug | HgI2 | 2.92e-10 | 11 | 85 | 5 | CID000024485 | |
| Drug | 2C KM | 2.92e-10 | 11 | 85 | 5 | CID009549196 | |
| Drug | chloroisocyanuric acid | 4.99e-10 | 12 | 85 | 5 | CID000017921 | |
| Drug | azaprophen | 4.99e-10 | 12 | 85 | 5 | CID000129486 | |
| Drug | methyl 1'-epiacarviosin | 8.09e-10 | 13 | 85 | 5 | CID000197426 | |
| Drug | isoacarbose | 8.09e-10 | 13 | 85 | 5 | CID000449165 | |
| Drug | GA15 | 8.09e-10 | 13 | 85 | 5 | CID000443453 | |
| Drug | Deposiston | 9.02e-10 | 5 | 85 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 9.02e-10 | 5 | 85 | 4 | CID010358258 | |
| Drug | lunularic acid | 9.02e-10 | 5 | 85 | 4 | CID000161413 | |
| Drug | himachalene | 9.02e-10 | 5 | 85 | 4 | CID000015095 | |
| Drug | actinidine | 9.02e-10 | 5 | 85 | 4 | CID000068231 | |
| Drug | 2TAA | 9.02e-10 | 5 | 85 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 9.02e-10 | 5 | 85 | 4 | CID006449879 | |
| Drug | silver perchlorate | 9.02e-10 | 5 | 85 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 9.02e-10 | 5 | 85 | 4 | CID000155287 | |
| Drug | Cyclodextrins | 1.25e-09 | 14 | 85 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 1.25e-09 | 14 | 85 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 1.25e-09 | 14 | 85 | 5 | CID000007488 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.88e-09 | 15 | 85 | 5 | CID000173254 | |
| Drug | R625 | 2.31e-09 | 33 | 85 | 6 | CID000072375 | |
| Drug | 2-amino-6-picoline | 2.70e-09 | 6 | 85 | 4 | CID000015765 | |
| Drug | phenol blue | 2.70e-09 | 6 | 85 | 4 | CID000075078 | |
| Drug | Gu-4 | 2.70e-09 | 6 | 85 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 2.70e-09 | 6 | 85 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 2.70e-09 | 6 | 85 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 2.70e-09 | 6 | 85 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 2.70e-09 | 6 | 85 | 4 | CID006857368 | |
| Drug | vermella | 2.70e-09 | 6 | 85 | 4 | CID000203726 | |
| Drug | hymenin | 2.70e-09 | 6 | 85 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 2.70e-09 | 6 | 85 | 4 | CID000011615 | |
| Drug | gamma-cyclodextrin | 2.72e-09 | 16 | 85 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 2.72e-09 | 16 | 85 | 5 | CID003085308 | |
| Drug | trimitan | 5.31e-09 | 18 | 85 | 5 | CID000005561 | |
| Drug | aprophen | 5.31e-09 | 18 | 85 | 5 | CID000071128 | |
| Drug | methyl blue | 6.28e-09 | 7 | 85 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 6.28e-09 | 7 | 85 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 6.28e-09 | 7 | 85 | 4 | CID000071762 | |
| Drug | amino-methyl | 6.28e-09 | 7 | 85 | 4 | CID000142005 | |
| Drug | validoxylamine A | 7.18e-09 | 19 | 85 | 5 | CID000161975 | |
| Drug | AC1L3XPY | 1.25e-08 | 21 | 85 | 5 | CID000124005 | |
| Drug | boric acid gel | 1.25e-08 | 8 | 85 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 1.25e-08 | 8 | 85 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 1.25e-08 | 8 | 85 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 1.25e-08 | 8 | 85 | 4 | CID000146692 | |
| Drug | acrinor | 1.25e-08 | 8 | 85 | 4 | CID005489637 | |
| Drug | NSC300622 | 1.25e-08 | 8 | 85 | 4 | CID000028426 | |
| Drug | theodrenaline | 1.25e-08 | 8 | 85 | 4 | CID000071857 | |
| Drug | rhodanile blue | 1.25e-08 | 8 | 85 | 4 | CID000073372 | |
| Drug | maltosaccharide | 1.61e-08 | 22 | 85 | 5 | CID005461034 | |
| Drug | GSAD | 2.25e-08 | 9 | 85 | 4 | CID009909127 | |
| Drug | GU-3 | 2.25e-08 | 9 | 85 | 4 | CID000448687 | |
| Drug | zingiberene | 2.25e-08 | 9 | 85 | 4 | CID000092776 | |
| Drug | Atonik | 2.25e-08 | 9 | 85 | 4 | CID000069471 | |
| Drug | H 187 | 2.25e-08 | 9 | 85 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 2.25e-08 | 9 | 85 | 4 | CID000024864 | |
| Drug | Panose B | 2.59e-08 | 24 | 85 | 5 | CID000439297 | |
| Drug | CID439354 | 3.22e-08 | 25 | 85 | 5 | CID000439354 | |
| Drug | I ZE | 3.73e-08 | 10 | 85 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 3.73e-08 | 10 | 85 | 4 | CID000012135 | |
| Drug | CG-120 | 3.73e-08 | 10 | 85 | 4 | CID000171403 | |
| Drug | eicosa-11,14-dienoic acid | 3.73e-08 | 10 | 85 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 3.73e-08 | 10 | 85 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 3.73e-08 | 10 | 85 | 4 | CID000440202 | |
| Drug | AC1N3UXZ | 5.02e-08 | 3 | 85 | 3 | CID004118625 | |
| Drug | Tempamine | 5.85e-08 | 11 | 85 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 5.85e-08 | 11 | 85 | 4 | CID000164608 | |
| Drug | AMO-1618 | 5.85e-08 | 11 | 85 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 5.85e-08 | 11 | 85 | 4 | CID000430710 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 8.52e-08 | 30 | 85 | 5 | CID005373003 | |
| Drug | glyciphosphoramide | 8.75e-08 | 12 | 85 | 4 | CID000197092 | |
| Drug | chitosan | 8.75e-08 | 12 | 85 | 4 | CID000071853 | |
| Drug | Avenin | 8.75e-08 | 12 | 85 | 4 | CID000095924 | |
| Drug | AC1L4W0B | 8.75e-08 | 12 | 85 | 4 | CID000193311 | |
| Disease | alpha-amylase 1 measurement | 8.38e-09 | 9 | 86 | 4 | EFO_0801371 | |
| Disease | nervous system disease (implicated_via_orthology) | 5.16e-06 | 12 | 86 | 3 | DOID:863 (implicated_via_orthology) | |
| Disease | synucleinopathy (biomarker_via_orthology) | 5.02e-05 | 4 | 86 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 5.02e-05 | 4 | 86 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | radius bone mineral density | 1.34e-04 | 34 | 86 | 3 | EFO_0007933 | |
| Disease | diet measurement | PRSS35 AMY1C PIK3R1 ZKSCAN2 SAMHD1 PTPN21 ACTR3B IL1R1 CSGALNACT1 AGAP1 DNMT3A | 2.33e-04 | 1049 | 86 | 11 | EFO_0008111 |
| Disease | eosinophil count | DHX16 FLI1 SLC9C1 SUPT5H LGALS14 USP7 C6orf163 ZKSCAN2 TSPAN32 IL1R1 ANKLE2 DNAH7 GABBR1 | 3.63e-04 | 1488 | 86 | 13 | EFO_0004842 |
| Disease | cocaine use | 4.54e-04 | 11 | 86 | 2 | C3496069 | |
| Disease | Autistic Disorder | 1.01e-03 | 261 | 86 | 5 | C0004352 | |
| Disease | Autism Spectrum Disorders | 1.99e-03 | 85 | 86 | 3 | C1510586 | |
| Disease | Degenerative polyarthritis | 2.57e-03 | 93 | 86 | 3 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 2.57e-03 | 93 | 86 | 3 | C0086743 | |
| Disease | body surface area | 2.75e-03 | 643 | 86 | 7 | EFO_0022196 | |
| Disease | Adenocarcinoma of large intestine | 2.81e-03 | 96 | 86 | 3 | C1319315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IEDHERIGYQVTAMI | 241 | Q9H2P0 | |
| VQEGCRYNVMHVAAK | 346 | Q86XL3 | |
| DYMQNVHGKEIDLLR | 386 | Q9UPQ3 | |
| KVQERYDSAVLGTMH | 401 | Q9NXR5 | |
| MCIEQDGRVHLTVVY | 286 | Q8TDX6 | |
| IMYVGDVRSVTQKHI | 681 | Q9Y6K1 | |
| KPVEVQVVTHHMQRY | 361 | Q9P1U1 | |
| RSKIAEYMNHLIDIG | 191 | P0DTE7 | |
| RSKIAEYMNHLIDIG | 191 | P0DTE8 | |
| VVNNHLEVARYMVQR | 726 | Q96KQ7 | |
| RSKIAEYMNHLIDIG | 191 | P0DUB6 | |
| REKEHEMSILYGIAQ | 211 | Q5TEZ5 | |
| IIGARAEMTSKHQEY | 136 | Q9NR28 | |
| RSKIAEYMNHLIDIG | 191 | P19961 | |
| AGEQEKLEATNRYHM | 286 | O60231 | |
| YHNVAERMQTRGKVP | 186 | Q9UJ41 | |
| NRAELYQHLKEENGM | 681 | Q9NVM9 | |
| LRINGVFVDKEEHMQ | 56 | Q5T2W1 | |
| RSKIAEYMNHLIDIG | 191 | P04746 | |
| MRQISEGVEYIHKQG | 1566 | Q15746 | |
| EHYVQVLKRMGNIRN | 831 | Q3B7T1 | |
| TEKINDHRAVGMAIY | 796 | Q9UBS5 | |
| NRVYNDIGKEMLLHA | 71 | O60333 | |
| KEGELHRTDYVRIMQ | 1121 | Q96MR6 | |
| VMYKKNHEQLEGNER | 436 | P42263 | |
| RGIMNYQEVEALKHT | 516 | Q9NZN1 | |
| KEVMNYRQTRHENVV | 656 | Q8IVT5 | |
| HRVNEKMGQIIQYDK | 601 | Q5GLZ8 | |
| YHIKDGVTRVGQVDM | 516 | O43896 | |
| IKDAYHMLKRQGIVQ | 131 | Q9NZ52 | |
| RYDLGGLVMVKDNHV | 161 | Q15274 | |
| QGRIHQIEYAMEAVK | 16 | P25786 | |
| GNEKEIQRIMHNYDK | 516 | P27986 | |
| YETVMKQLNRGLVHA | 451 | Q16825 | |
| AMRIGAEVYHNLKNV | 181 | P06733 | |
| EVLVVADNRMVSYHG | 296 | Q9P2N4 | |
| MKYVTDVGVLQRHVS | 236 | O75419 | |
| KIAEIRKDMSGHYQN | 721 | P53621 | |
| IKQMRIIHGAGYSEE | 56 | P29992 | |
| INRIIKVMKHEAYGE | 231 | P12110 | |
| ENHLETKMINAGLRY | 1276 | Q8WXX0 | |
| PVRVNVKREYDHMNG | 61 | Q01543 | |
| VRMKQLISEHYVGAV | 131 | Q3B7J2 | |
| DKIIMYDQNHLLGRA | 121 | Q6PD62 | |
| HMGRLSDVQIYVDKV | 106 | P09913 | |
| DIIHNENMRQGRDKY | 551 | P15311 | |
| KDLDAVRMIYSQHVQ | 576 | Q9NYC9 | |
| RAIQRMEKGEHSIVY | 206 | Q02790 | |
| ARQEHTELMEQYKGI | 191 | Q9P1Z2 | |
| LIVMNVAEKHRGNYT | 181 | P14778 | |
| NQGELDAMEYHTKIR | 141 | Q8N3J2 | |
| DEVEKRHQISMAVIY | 171 | Q9H6A0 | |
| KQVYRDIGEEMLQHA | 71 | Q12756 | |
| DQVYGDQDMHEVVRK | 231 | Q96G74 | |
| IQDYEENKARVHLVM | 236 | O14832 | |
| QGEIYRSIEHLDKMG | 206 | Q9Y316 | |
| EGMRVGVDRNKYQIH | 136 | P35998 | |
| QEERQGKMLLHTEYS | 81 | Q8N2I9 | |
| IRNMEHAIKELGYLE | 781 | Q4G0N8 | |
| VKNHLMYAVREEVEI | 61 | Q99576 | |
| RHMVLLKEQYGQQVV | 286 | O15056 | |
| RRAYQHKVGNIIDTM | 371 | Q9Y3Z3 | |
| RPGRTVYAQMHNEKE | 1106 | Q96PQ0 | |
| LNMYGKVVTVRHQAV | 561 | O00267 | |
| DVRKYTNNLGIVHEM | 41 | Q86UD7 | |
| VYKDITHGNRQMTVI | 96 | Q13405 | |
| LDDILYHVKGMQRIV | 906 | Q96QB1 | |
| VMRNDGALYHNNEEK | 101 | Q5W111 | |
| NLQIAVDRMHKGVAY | 1011 | P35498 | |
| YKNQGRILRNHMEEG | 56 | Q8TBZ8 | |
| YEQAMKGTSHVRRQE | 131 | Q96QS1 | |
| VDVHGVQKDYNVAVR | 376 | Q8N3Z0 | |
| SEYLKHNVRGVVSMA | 76 | Q9H2H8 | |
| DELVNKSHMGYEQVR | 801 | Q9UKY1 | |
| QHMPEVEVQVKYRTA | 16 | B1AK76 | |
| MNYHQGLKTELEARV | 1981 | Q9H254 | |
| VYKVRHRQSGQVMVL | 71 | Q15569 | |
| LMKYHQGINAEIETR | 1941 | P11277 | |
| KLRSGMAQQIAYEIH | 1061 | Q86X10 | |
| RHKEYKVMVNGQRIY | 96 | Q8TCE9 | |
| DPTQIVYKDMEQHRA | 671 | Q63HK3 | |
| DVRKYTNNLGIVHEM | 41 | Q2M2D7 | |
| DMIAILDYHNQVRGK | 66 | O43692 | |
| GYIRVLVHEGKQVMA | 1121 | P35442 | |
| KERQEAHLYMQVQIV | 556 | Q93009 | |
| ERNADGTIKYVHMQL | 111 | Q13459 | |
| LVHYMNVAKIQSDRE | 1111 | P20929 |